Cases of Interest
Media Tech Law Blog
Sign Up for Email Alerts
Chief Marketing Officer
Orchid Can't Nix Roche Boniva Patent
March 18, 2011 |
Loeb & Loeb LLP's
are noted as counsel for Hoffmann-La Roche Inc. in the pharmaceutical company's infringement actions against Orchid Chemicals & Pharmaceuticals Ltd. over Orchid's proposed generic version of the branded osteoporosis drug Boniva
. A federal judge rejected Orchid's bid to toss one of the five Boniva
patents asserted by Roche to prevent Orchid from marketing the generic drug.
Mark E. Waddell
Paula K. Colbath
Joshua H. Harris
Patent Litigation and Counseling
This Web site may constitute "Attorney Advertising" under the New York Rules of Professional Conduct and under the law of other jurisdictions.
Your use of our Web site or its facilities constitutes your acceptance of the
, which are accessible in the link at the bottom left of this page.